Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00062101
Status:
COMPLETED
Last Update Posted:
2013-06-06
First Post:
2003-06-05
Brief Title:
Erlotinib and Celecoxib in Treating Patients With Stage IIIB or Stage IV Recurrent Non-Small Cell Lung Cancer
Sponsor:
Organization:
National Cancer Institute NCI